株式会社PURMX Therapeutics

PURMX is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

株式会社PURMX Therapeutics is active in the medtech space based in Tokyo, Japan.

Profile

"PURMX Therapeutics is a pioneering medtech company dedicated to developing RNA nucleic acid medicine for treating intractable diseases. With a focus on replenishing small molecule RNA in cells, PURMX is at the forefront of revolutionary drug development, aiming to transform the industry. Since its inception, PURMX has been committed to developing innovative nucleic acid therapeutics to help patients suffering from challenging diseases. By leveraging proprietary platform technologies, the company creates tailored nucleic acid medicines for disease treatment, fine-tuning numerous target genes to deliver unprecedented therapeutic effects. With a wealth of functional RNA screening data, PURMX is driving groundbreaking nucleic acid medicine projects like MIRX002. Driven by a mission to overcome challenges and unite as a team to save patients, PURMX Therapeutics is dedicated to pushing the boundaries of medical innovation."

As a business in medtech, 株式会社PURMX Therapeutics is listed here with the public details available about it.

Tokyo, Japan is where the company is located.

It is recorded at the Plug and Play portfolio startup stage.

Website: www.purmx.com